WaveMan
WaveMan · Company
MODD · Modular Medical, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

MODD Modular Medical (MODD) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001074871
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
14
13F, latest reported quarter

Modular Medical insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Modular Medical, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
MANCHESTER MANAGEMENT PR, LLC
Chief Executive Officer
BUY
2025-03-24 SECtraded 2025-03-20
520,832
$1.0M
-94.9%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Dec 3, 2024.
  • +0.0% median (-13.6% mean) 90-day return after 4 previous buys.
  • The trade is 13.7% of the 3,805,575 shares held after it.
  • No other insider bought within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MANCHESTER MANAGEMENT PR, LLC bought about $1,000.0K of MODD on Mar 20, 2025, the largest insider purchase at the company since 2022; 14 funds added in the latest 13F quarter.
MANCHESTER MANAGEMENT PR, LLC
Chief Executive Officer
BUY
2025-03-24 SECtraded 2025-03-20
156,250
$300.0K
-94.9%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Dec 3, 2024.
  • +0.0% median (-13.6% mean) 90-day return after 4 previous buys.
  • The trade is 37.0% of the 422,000 shares held after it.
  • No other insider bought within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MANCHESTER MANAGEMENT PR, LLC bought about $300.0K of MODD on Mar 20, 2025, the largest insider purchase at the company since 2024; 14 funds added in the latest 13F quarter.
MANCHESTER MANAGEMENT PR, LLC
Chief Executive Officer
BUY
2024-12-04 SECtraded 2024-12-03
21,000
$35.3K
-96.6%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Feb 16, 2024.
  • +0.0% median (+0.0% mean) 90-day return after 3 previous buys.
  • The trade is 7.9% of the 265,750 shares held after it.
  • 2 other insiders bought within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MANCHESTER MANAGEMENT PR, LLC bought about $35.3K of MODD on Dec 3, 2024; 2 other insiders bought within 30 days and 14 funds added in the latest 13F quarter.
JEB Partners, L.P.
Chief Executive Officer
BUY
2024-11-29 SECtraded 2024-11-27
100,000
$169.0K
-96.6%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Oct 16, 2023.
  • The trade is 40.9% of the 244,750 shares held after it.
  • 2 other insiders bought within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer JEB Partners, L.P. bought about $169.0K of MODD on Nov 27, 2024; 2 other insiders bought within 30 days and 14 funds added in the latest 13F quarter.
MANCHESTER MANAGEMENT CO LLC
Chief Executive Officer
BUY
2024-11-25 SECtraded 2024-11-21
166,666
$250.0K
-96.4%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Nov 20, 2018.
  • The trade is 5.1% of the 3,284,743 shares held after it.
  • 2 other insiders bought within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer MANCHESTER MANAGEMENT CO LLC bought about $250.0K of MODD on Nov 21, 2024; 2 other insiders bought within 30 days and 14 funds added in the latest 13F quarter.
26 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 21 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
14 funds bought in last quarter
below 78% of Medical Devices
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
5.5% of the float short (float per yahoo 2026-10-26) · 3.7 days to cover · settled 2026-09-30
more than 63% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch MODD

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-90.0%12M
-90%-60%-30%-0%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns MODD: institutional holders (13F)

13F holdings, latest reported quarter
AWM Investment Company, Inc.
441,095 sh
$2.0M
Solas Capital Management, LLC
438,095 sh
$2.0M
Bleichroeder LP
336,986 sh
$1.5M
683 Capital Management, LLC
130,000 sh
$585.0K
VANGUARD CAPITAL MANAGEMENT LLC
103,182 sh
$464.3K

Congress trades in MODD

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

MODD planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

MODD mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
VANGUARD EXTENDED MARKET INDEX FUND
$240.9K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$82.2K position · as of 2026-05-31
0.0%
Fidelity Nasdaq Composite Index Fund
$17.2K position · as of 2026-05-31
0.0%
Fidelity Total Market Index Fund
$14.3K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$9.8K position · as of 2026-05-31
0.0%
VANGUARD TOTAL STOCK MARKET INDEX FUND
$185.6K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$47.0K
$17.1K
$519.3K
n/a
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. This filer reported no return figures.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 14 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

MODD financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$0
four quarters, 2018-01-01 to 2018-12-31
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Free cash flow, TTM
-$28.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
-247.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-212.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-238.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no debt line filed
FCF yield
-196.6%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2026-032025-032024-032023-03
Operating income-$27.6M-$19.0M-$17.5M-$13.9M
Net income-$28.2M-$18.8M-$17.5M-$13.9M
EPS (diluted)-12.36-15.26-0.78-1.15
Operating cash flow-$23.8M-$15.7M-$14.0M-$11.0M
Cash$6.9M$13.1M$9.2M$3.8M
SEC XBRL, fiscal years, as known on 2026-10-27

MODD Stock Sonar score 3/7 axes

Find similar shapesCompare

MODD ranks highest on risk and compliance (48th percentile) and institutional and government (22nd), and lowest on profitability (9th), among Medical Devices peers.

Profitability
9
Inputs
  • Return on equity-247.9% · 12 pct, sector of 183
  • Return on assets-212.1% · 7 pct, sector of 214
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-238.5% · 7 pct, sector of 188
Institutional and government
22
Inputs
  • Funds adding, latest quarter14 · 22 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
48
Inputs
  • Short interest, % of float+5.5% · 45 pct, sector of 240
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+10.6% · 51 pct, sector of 198
4 not measured: Financial health, Growth, Insider conviction, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies